Cite
HARVARD Citation
Pisani, L. et al. (n.d.). DOP36 Vedolizumab-treated IBD patients show an increased gut microbial diversity associated with a specific serum metabolic signature. Journal of Crohn's and colitis. pp. i99-i101. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pisani, L. et al. (n.d.). DOP36 Vedolizumab-treated IBD patients show an increased gut microbial diversity associated with a specific serum metabolic signature. Journal of Crohn's and colitis. pp. i99-i101. [Online].